Yingru Zhang - Concepedia

Author

Yingru Zhang

Bristol-Myers Squibb (United States)ORCID

Also Known As

Ying-Ru Zhang, Yingru Zhang, Zhang, Yingru

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Centre National de la Recherche Scientifique Université d'Orléans Shuguang Hospital Shanghai University of Traditional Chinese Medicine

About

Yingru Zhang is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	998
2	Engineering	9	9	310
3	Natural Sciences	9	9	533
4	Arts	1	1	153
5	Health Sciences	1	1	60

Yingru Zhang

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Discovery of <i>N</i>-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily Gretchen M. Schroeder, Yongmi An, Zhen‐Wei Cai, Journal of Medicinal Chemistry Orally Efficacious InhibitorDrug TargetPharmacotherapyPharmaceutical ChemistryTumor Biology	2009	276
How does self-esteem affect mobile phone addiction? The mediating role of social anxiety and interpersonal sensitivity Zhiqi You, Yingru Zhang, Lu Zhang, Psychiatry Research Self-esteem AffectBehavioral SciencesInterpersonal CommunicationSocial PsychologyArts	2018	153
Discovery of 6-Fluoro-5-(<i>R</i>)-(3-(<i>S</i>)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(<i>S</i>)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton’s Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers Scott H. Watterson, George V. De Lucca, Qing Shi, Journal of Medicinal Chemistry	2016	142
Capillary Isoelectric Focusing-Mass Spectrometry Method for the Separation and Online Characterization of Intact Monoclonal Antibody Charge Variants Jun Dai, Jared Lamp, Qiangwei Xia, Analytical Chemistry	2017	116
Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway Shiyun Shao, Ru Jia, Ling Zhao, Phytomedicine	2021	109
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors Ashvinikumar V. Gavai, Claude Quesnelle, Derek Norris, ACS Medicinal Chemistry Letters Solid TumorsPharmacotherapyTumor BiologyMyeloid NeoplasiaHematological Malignancy	2015	88
Insights into chiral recognition mechanisms in supercritical fluid chromatography. II. Factors contributing to enantiomer separation on tris-(3,5-dimethylphenylcarbamate) of amylose and cellulose stationary phases Caroline West, Guillaume Guénegou, Yingru Zhang, Journal of Chromatography A EngineeringBiochemistrySupercritical Fluid ChromatographyChiral Recognition MechanismsSupercritical Flow	2010	65
Identification of 1- and 3-methylhistidine as biomarkers of skeletal muscle toxicity by nuclear magnetic resonance-based metabolic profiling Nelly Aranı́bar, Jeffrey D. Vassallo, John A. Rathmacher, Analytical Biochemistry Energy MetabolismBiochemistryPhysiologyMetabolomic ProfilingSkeletal Muscle Toxicity	2010	60
Effects of column back pressure on supercritical fluid chromatography separations of enantiomers using binary mobile phases on 10 chiral stationary phases Chunlei Wang, Yingru Zhang Journal of Chromatography A Binary Mobile PhasesSupercritical Fluid ChromatographySeparation ScienceChiral Stationary PhasesSupercritical Flow	2013	58
Insights into chiral recognition mechanisms in supercritical fluid chromatography. I. Non-enantiospecific interactions contributing to the retention on tris-(3,5-dimethylphenylcarbamate) amylose and cellulose stationary phases Caroline West, Yingru Zhang, Luc Morin‐Allory Journal of Chromatography A EngineeringBiochemistrySupercritical Fluid ChromatographyChiral Recognition MechanismsSupercritical Flow	2010	52

Page 1